Post-Treatment Biomarker Changes Improved Breast Cancer Survival

About 40% of women experienced a change in at least one biomarker from primary to residual breast cancer after undergoing neoadjuvant chemotherapy, according to the results of a study presented at the ASCO Breast Cancer Symposium.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news